慢性肾脏病各阶段心肌异常的界定:一项心脏磁共振成像研究
这项概念验证横断面研究纳入134例非糖尿病、未透析的CKD 2至5期且无心肌缺血的患者,行1.5T心脏磁共振T1 mapping、T2 mapping、延迟钆增强及主动脉扩张性评估,并检测血清纤维化标志物。结果显示天然心肌T1时间从2期至5期递增(966±21 ms vs. 994±33 ms,p<0.001),且eGFR是T1时间最强预测因子;T1时间、左房扩大和高敏肌钙蛋白T是%预测VO2Peak的独立预测因子。
要点
- CKD 2至5期天然心肌T1时间递增,提示弥漫性纤维化随肾病进展加重。
- eGFR是天然心肌T1时间的最强预测因子(多变量线性回归,p<0.001)。
- 天然心肌T1时间、左房扩大和高敏肌钙蛋白T独立预测%预测VO2Peak(p<0.001)。
关键影像表现/征象
- 天然心肌T1时间从CKD 2期至5期递增(966±21 ms vs. 994±33 ms,p<0.001),独立于高血压和主动脉扩张性。
- 左房容积、E/e'、NT-proBNP、P1NP和P3NP随CKD分期增加(p<0.05)。
- 运动耐量(%预测VO2Peak、%VO2VT)随CKD分期降低(p<0.001)。
诊断标准与关键数值
- 天然心肌T1时间:CKD 2期966±21 ms vs. CKD 5期994±33 ms(p<0.001)。
- 多变量线性回归中eGFR是天然心肌T1时间的最强预测因子(p<0.001)。
- 天然心肌T1时间、左房扩大和高敏肌钙蛋白T是%预测VO2Peak的独立预测因子(p<0.001)。
临床应用与阅片要点
- 在CKD患者心脏磁共振检查中,天然心肌T1时间升高提示弥漫性心肌纤维化,且随CKD分期加重。
- 左房容积增大和E/e'升高随CKD分期进展,结合T1时间可评估尿毒症心肌病的心肌受累。
局限性
- 原文结论指出需进一步研究确定这些变化是否导致CKD中心力衰竭和死亡增加。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: A proof of concept cross-sectional study investigating changes in myocardial abnormalities across stages of chronic kidney disease (CKD). Characterizing noninvasive markers of myocardial fibrosis on cardiac magnetic resonance, echocardiography, and correlating with biomarkers of fibrosis, myocardial injury, and functional correlates including exercise tolerance.
BACKGROUND: CKD is associated with an increased risk of cardiovascular death. Much of the excess mortality is attributed to uremic cardiomyopathy, defined by increased left ventricular hypertrophy, myocardial dysfunction, and fibrosis. The prevalence of these abnormalities across stages of CKD and their impact on cardiovascular performance is unknown.
METHODS: A total of 134 nondiabetic, pre-dialysis subjects with CKD stages 2 to 5 without myocardial ischemia underwent cardiac magnetic resonance (1.5-T) including; T1 mapping (biomarker of diffuse fibrosis), T2 mapping (edema), late gadolinium enhancement, and assessment of aortic distensibility. Serum biomarkers including collagen turnover (P1NP, P3NP), troponin T, and N-terminal pro-B-type natriuretic peptide were measured. Cardiovascular performance was quantified by bicycle cardiopulmonary exercise testing and echocardiography.
RESULTS: Native myocardial T1 times increased incrementally from stage 2 to 5 (966 ± 21 ms vs. 994 ± 33 ms; p < 0.001), independent of hypertension and aortic distensibility. Left atrial volume, E/e', N-terminal pro-B-type natriuretic peptide, P1NP, and P3NP increased with CKD stage (p < 0.05), while effort tolerance (% predicted VO2Peak, %VO2VT) decreased (p < 0.001). In multivariable linear regression models, estimated glomerular filtration rate was the strongest predictor of native myocardial T1 time (p < 0.001). Native myocardial T1 time, left atrial dilatation, and high-sensitivity troponin T were independent predictors of % predicted VO2Peak (p < 0.001).
CONCLUSIONS: Imaging and serum biomarkers of myocardial fibrosis increase with advancing CKD independent of effects of left ventricular afterload and might be a key intermediary in the development of uremic cardiomyopathy. Further studies are needed to determine whether these changes lead to the increased rates of heart failure and death in CKD. (Left Ventricular Fibrosis in Chronic Kidney Disease [FibroCKD]; NCT03176862).
引用
- Hayer MK, Radhakrishnan A, Price AM, et al. Defining Myocardial Abnormalities Across the Stages of Chronic Kidney Disease: A Cardiac Magnetic Resonance Imaging Study. JACC Cardiovasc Imaging. 2020. PMID: 32682713. doi:10.1016/j.jcmg.2020.04.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。